Cresco Labs Analyst Ratings
Cresco Labs Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
12/20/2022 | 17.16% | Cowen & Co. | $7 → $2.5 | Downgrades | Outperform → Market Perform |
12/02/2022 | 110.88% | Wedbush | → $4.5 | Initiates Coverage On | → Outperform |
08/18/2022 | 181.18% | Piper Sandler | $9 → $6 | Maintains | Overweight |
08/18/2022 | 602.94% | Cantor Fitzgerald | $19 → $15 | Maintains | Overweight |
03/24/2022 | 321.76% | Piper Sandler | $14 → $9 | Maintains | Overweight |
11/15/2021 | 790.39% | Cantor Fitzgerald | $12 → $19 | Maintains | Overweight |
11/03/2021 | 462.35% | Cantor Fitzgerald | $12.65 → $12 | Maintains | Overweight |
08/05/2021 | 532.64% | Cantor Fitzgerald | $21.5 → $13.5 | Maintains | Overweight |
07/07/2021 | 1587.05% | Jefferies | → $36 | Initiates Coverage On | → Buy |
01/20/2021 | 884.11% | Cantor Fitzgerald | $18 → $21 | Maintains | Overweight |
11/19/2020 | 743.53% | Cantor Fitzgerald | $16 → $18 | Maintains | Overweight |
10/30/2020 | 649.8% | Cantor Fitzgerald | $15 → $16 | Maintains | Overweight |
08/21/2020 | 602.94% | Cantor Fitzgerald | $11 → $15 | Maintains | Overweight |
06/12/2020 | 96.82% | Needham | → $4.2 | Initiates Coverage On | → Hold |
05/29/2020 | 415.49% | Cantor Fitzgerald | $9.5 → $11 | Maintains | Overweight |
05/27/2020 | 345.19% | Cantor Fitzgerald | $8 → $9.5 | Maintains | Overweight |
04/28/2020 | 274.9% | Cantor Fitzgerald | $10 → $8 | Maintains | Overweight |
03/30/2020 | 368.63% | Cantor Fitzgerald | $12 → $10 | Maintains | Overweight |
02/14/2020 | 462.35% | Cantor Fitzgerald | → $12 | Initiates Coverage On | → Overweight |
09/13/2019 | 556.08% | Cowen & Co. | → $14 | Initiates Coverage On | → Outperform |
08/13/2019 | 415.49% | Piper Sandler | → $11 | Initiates Coverage On | → Overweight |
日期 | 上/下行 | 分析師公司 | 价格目標變更 | 評級變更 | 上一頁/目前評分 |
---|---|---|---|---|---|
12/20/2022 | 17.16% | 科恩 & 有限公司. | 7 美元 → 2.5 美元 | 降級 | 跑贏大市 → 市場表現 |
2022 年 12 月 2 日 | 110.88% | Wedbush | → 4.5 美元 | 啟動覆蓋範圍 | → 跑贏大市 |
08/18/2022 | 181.18% | 吹笛者桑德勒 | 9 美元 → 6 美元 | 維護 | 超重 |
08/18/2022 | 602.94% | 康托·菲茨杰拉德 | 十九元 → 15 美元 | 維護 | 超重 |
03/24/2022 | 321.76% | 吹笛者桑德勒 | 十四美元 → 9 美元 | 維護 | 超重 |
11/15/2021 | 790.39% | 康托·菲茨杰拉德 | 十二美元 → 十九美元 | 維護 | 超重 |
11/03/2021 | 462.35% | 康托·菲茨杰拉德 | 十二美元 → 十二美元 | 維護 | 超重 |
08/05/2021 | 532.64% | 康托·菲茨杰拉德 | 二十五美元 → 13.5 美元 | 維護 | 超重 |
2021 年 7 月 7 日 | 1587.05% | 富瑞集團 | → 三十六美元 | 啟動覆蓋範圍 | → 購買 |
01/20/2021 | 884.11% | 康托·菲茨杰拉德 | 十八美元 → 二十一美元 | 維護 | 超重 |
11/19/2020 | 743.53% | 康托·菲茨杰拉德 | 十六美元 → 十八美元 | 維護 | 超重 |
10/30/2020 | 649.8% | 康托·菲茨杰拉德 | 15 美元 → 16 美元 | 維護 | 超重 |
08/21/2020 | 602.94% | 康托·菲茨杰拉德 | 十一元 → 15 美元 | 維護 | 超重 |
2020 年 12 月 6 日 | 96.82% | 李約瑟 | → 4.2 美元 | 啟動覆蓋範圍 | → 保持 |
2020 年 5 月 29 日 | 415.49% | 康托·菲茨杰拉德 | 9 美元 → 11 美元 | 維護 | 超重 |
2020 年 5 月 27 日 | 345.19% | 康托·菲茨杰拉德 | 8 美元 → 9.5 美元 | 維護 | 超重 |
04/28/2020 | 274.9% | 康托·菲茨杰拉德 | 十美元 → 8 美元 | 維護 | 超重 |
03/30/2020 | 368.63% | 康托·菲茨杰拉德 | 十二元 → 十美元 | 維護 | 超重 |
02/14/2020 | 462.35% | 康托·菲茨杰拉德 | → 十二美元 | 啟動覆蓋範圍 | → 超重 |
09/13/2019 | 556.08% | 科恩 & 有限公司. | → 十四美元 | 啟動覆蓋範圍 | → 跑贏大市 |
08/13/2019 | 415.49% | 吹笛者桑德勒 | → 11 美元 | 啟動覆蓋範圍 | → 超重 |
What is the target price for Cresco Labs (CRLBF)?
克雷斯科實驗室(CRLBF)的目標價格是多少?
The latest price target for Cresco Labs (OTCQX: CRLBF) was reported by Cowen & Co. on December 20, 2022. The analyst firm set a price target for $2.50 expecting CRLBF to rise to within 12 months (a possible 17.16% upside). 5 analyst firms have reported ratings in the last year.
科文公司於 2022 年 12 月 20 日報導了克雷斯科實驗室(OTCQX:CRLBF)的最新價格目標。該分析師公司設定了 2.50 美元的價格目標,預計 CRLBF 將在 12 個月內上升(可能是 17.16% 的上漲情況)。5 家分析師公司在去年報告了評級。
What is the most recent analyst rating for Cresco Labs (CRLBF)?
克雷斯科實驗室(CRLBF)的最新分析師評級為何?
The latest analyst rating for Cresco Labs (OTCQX: CRLBF) was provided by Cowen & Co., and Cresco Labs downgraded their market perform rating.
克雷斯科實驗室的最新分析師評級(OTCQX:CRLBF)由科文公司提供,克雷斯科實驗室降級了其市場表現評級。
When is the next analyst rating going to be posted or updated for Cresco Labs (CRLBF)?
什麼時候將發布或更新克雷斯科實驗室(CRLBF)的下一個分析師評級?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cresco Labs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cresco Labs was filed on December 20, 2022 so you should expect the next rating to be made available sometime around December 20, 2023.
分析師在進行了廣泛的研究後獲得了股票評級,其中包括通過公共財務報表,與 Cresco Labs 的高管和客戶交談以及收聽盈利會議電話會議。大多數分析師每三個月這樣做一次,因此您應該每年每家公司獲得 4 個評級。克雷斯科實驗室的最後評級於 2022 年 12 月 20 日提交,因此您應該期望下一個評分將在 2023 年 12 月 20 日左右的某個時間提供。
Is the Analyst Rating Cresco Labs (CRLBF) correct?
分析師評級克雷斯科實驗室(CRLBF)是否正確?
While ratings are subjective and will change, the latest Cresco Labs (CRLBF) rating was a downgraded with a price target of $7.00 to $2.50. The current price Cresco Labs (CRLBF) is trading at is $2.13, which is out of the analyst's predicted range.
雖然評分是主觀的並且會發生變化,但最新的克雷斯科實驗室(CRLBF)評級降級,目標價格為 7.00 美元至 2.50 美元。當前價格克雷斯科實驗室(CRLBF)的交易價格為 2.13 美元,超出了分析師的預測範圍。
譯文內容由第三人軟體翻譯。